Design Therapeutics Inc
DSGN3.960USD
+0.140+3.66%
收盘 08/04, 16:00（美东）报价延迟15分钟
224.80M总市值
亏损市盈率 TTM
关于 Design Therapeutics Inc 公司
Design Therapeutics, Inc. 是一家生物技术公司。该公司从事 GeneTACT 分子的研究和开发，GeneTACT 分子是小分子基因靶向嵌合治疗候选药物，旨在通过解决遗传性核苷酸重复扩增突变导致的疾病的根本原因来改善疾病。其弗里德赖希共济失调 (FA) 项目专注于开发改善疾病的治疗方法。其 DT-216 旨在克服导致 FA 的 FXN 转录障碍。DT-216 处于 I 期临床试验阶段。该公司还致力于开发 DT-216，以实现更高的暴露量和长期给药以治疗 FA，称为 DT-216P2，它使用相同的药物物质 DT-216。其 FECD 项目专注于开发一种可能改善疾病的 FECD 医疗治疗方法 DT-168，目前处于 I 期临床试验阶段。其 HD 项目专注于开发一种可能改善疾病的 HD 治疗方法。
公司简介
公司代码DSGN
公司名称Design Therapeutics Inc
上市日期Mar 26, 2021
CEODr. Pratik Shah, Ph.D.
员工数量54
证券类型Ordinary Share
年结日Mar 26
公司地址6005 Hidden Valley Road
城市CARLSBAD
上市交易所NASDAQ Global Select Consolidated
国家United States of America
邮编92011
电话18582934900
网址https://www.designtx.com/
公司代码DSGN
上市日期Mar 26, 2021
CEODr. Pratik Shah, Ph.D.
公司高管
名称
名称/职务
职务
持股
持股变动
Dr. Rodney W. Lappe, Ph.D.
Dr. Rodney W. Lappe, Ph.D.
Independent Director
Independent Director
133.02K
--
Dr. Pratik Shah, Ph.D.
Dr. Pratik Shah, Ph.D.
Chairman of the Board, President, Chief Executive Officer, Principal Financial Officer
Chairman of the Board, President, Chief Executive Officer, Principal Financial Officer
129.92K
--
Mr. John P. Schmid
Mr. John P. Schmid
Independent Director
Independent Director
57.64K
--
Ms. Deepa Prasad
Ms. Deepa Prasad
Independent Director
Independent Director
20.00K
--
Dr. Heather A Berger ,Ph.D.
Dr. Heather A Berger ,Ph.D.
Independent Director
Independent Director
1.30K
--
Dr. Sean Jeffries, Ph.D.
Dr. Sean Jeffries, Ph.D.
Chief Operating Officer
Chief Operating Officer
--
--
Dr. Christopher M. (Chris) Storgard, M.D.
Dr. Christopher M. (Chris) Storgard, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Dr. Simeon J. George, M.D.
Dr. Simeon J. George, M.D.
Lead Independent Director
Lead Independent Director
--
--
Dr. Arsani H. William, M.D.
Dr. Arsani H. William, M.D.
Independent Director
Independent Director
--
--
名称
名称/职务
职务
持股
持股变动
Dr. Rodney W. Lappe, Ph.D.
Dr. Rodney W. Lappe, Ph.D.
Independent Director
Independent Director
133.02K
--
Dr. Pratik Shah, Ph.D.
Dr. Pratik Shah, Ph.D.
Chairman of the Board, President, Chief Executive Officer, Principal Financial Officer
Chairman of the Board, President, Chief Executive Officer, Principal Financial Officer
129.92K
--
Mr. John P. Schmid
Mr. John P. Schmid
Independent Director
Independent Director
57.64K
--
Ms. Deepa Prasad
Ms. Deepa Prasad
Independent Director
Independent Director
20.00K
--
Dr. Heather A Berger ,Ph.D.
Dr. Heather A Berger ,Ph.D.
Independent Director
Independent Director
1.30K
--
Dr. Sean Jeffries, Ph.D.
Dr. Sean Jeffries, Ph.D.
Chief Operating Officer
Chief Operating Officer
--
--
收入明细
暂无数据
暂无数据
业务
地区
暂无数据
股东统计
更新时间: 5月17日 周六
更新时间: 5月17日 周六
持股股东
股东类型
持股股东
持股股东
占比
Ansari (Aseem Z. Ph.D.)
13.51%
SR One Capital Management, LP
11.50%
Logos Global Management LP
7.43%
Quan Venture Fund II LP
7.04%
Light Irrevocable Trust.
6.75%
Other
53.77%
持股股东
持股股东
占比
Ansari (Aseem Z. Ph.D.)
13.51%
SR One Capital Management, LP
11.50%
Logos Global Management LP
7.43%
Quan Venture Fund II LP
7.04%
Light Irrevocable Trust.
6.75%
Other
53.77%
股东类型
持股股东
占比
Corporation
20.55%
Venture Capital
18.93%
Hedge Fund
15.58%
Individual Investor
15.54%
Investment Advisor
13.62%
Investment Advisor/Hedge Fund
8.75%
Private Equity
3.44%
Research Firm
0.58%
Pension Fund
0.09%
Other
2.92%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
236
55.16M
97.16%
-18.43M
2025Q1
248
55.19M
97.22%
-19.02M
2024Q4
263
54.33M
95.95%
-18.64M
2024Q3
271
52.86M
93.39%
-18.89M
2024Q2
270
52.91M
93.60%
-20.44M
2024Q1
269
51.55M
91.19%
-22.56M
2023Q4
256
52.68M
94.11%
-19.20M
2023Q3
248
54.08M
96.62%
-10.45M
2023Q2
240
59.86M
106.99%
-4.32M
2023Q1
237
59.61M
106.56%
-4.74M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Ansari (Aseem Z. Ph.D.)
7.67M
13.51%
--
--
Mar 31, 2025
SR One Capital Management, LP
6.53M
11.5%
--
--
Mar 31, 2025
Logos Global Management LP
4.22M
7.43%
--
--
Mar 31, 2025
Quan Venture Fund II LP
4.00M
7.04%
-133.00K
-3.22%
Mar 31, 2025
Light Irrevocable Trust.
3.83M
6.75%
--
--
Mar 31, 2025
Star Irrevocable Trust.
3.83M
6.75%
--
--
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
2.20M
3.88%
-73.03K
-3.21%
Mar 31, 2025
Frazier Life Sciences Management, L.P.
1.95M
3.44%
--
--
Mar 31, 2025
Point72 Asset Management, L.P.
1.82M
3.2%
-38.89K
-2.09%
Mar 31, 2025
Baker Bros. Advisors LP
1.74M
3.07%
--
--
Mar 31, 2025
查看更多
持股ETF
更新时间: 8月2日 周六
更新时间: 8月2日 周六
机构名称
占比
ProShares Ultra Nasdaq Biotechnology
0.02%
Invesco Nasdaq Biotechnology ETF
0.02%
iShares Micro-Cap ETF
0.02%
Fidelity Enhanced Small Cap ETF
0.01%
iShares Russell 2000 Value ETF
0.01%
iShares Biotechnology ETF
0.01%
Avantis US Small Cap Equity ETF
0.01%
Schwab U.S. Small-Cap ETF
0%
Global X Russell 2000 ETF
0%
Global X Russell 2000 Covered Call ETF
0%
查看更多
ProShares Ultra Nasdaq Biotechnology
占比0.02%
Invesco Nasdaq Biotechnology ETF
占比0.02%
iShares Micro-Cap ETF
占比0.02%
Fidelity Enhanced Small Cap ETF
占比0.01%
iShares Russell 2000 Value ETF
占比0.01%
iShares Biotechnology ETF
占比0.01%
Avantis US Small Cap Equity ETF
占比0.01%
Schwab U.S. Small-Cap ETF
占比0%
Global X Russell 2000 ETF
占比0%
Global X Russell 2000 Covered Call ETF
占比0%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
